<DOC>
	<DOCNO>NCT01052870</DOCNO>
	<brief_summary>Previous study finasteride treatment woman hair loss fail show positive result , yet , woman respond anecdotally . Given polymorphisms androgen receptor gene confer androgen sensitivity impact male response finasteride therapy , hypothesize polymorphism woman may identify group respond . This study design test impact finasteride therapy hair loss postmenopausal woman .</brief_summary>
	<brief_title>Association Polymorphisms Androgen Receptor Gene Finasteride Response Women With Androgenetic Alopecia</brief_title>
	<detailed_description>Androgen sensitivity cell determine number Cytosine-Adenine-Guanine repeat Androgen Receptor gene . Lower CAG repeat associate previous study androgenic condition acne , hirsutism hair loss men woman . Keeping mind , test woman hair loss frontal vertex area , AR genotype . Patients randomize placebo 1 mg finasteride therapy 6 month . Global photograph 2 tatooed area 1cm2 measure monthly ass global appearance hair count medication impact .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>woman hair loss pre menopausal , metabolic medication nonandrogenetic cause hair loss , diffuse hair loss</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>pharmacogenomics , androgen receptor gene , androgen sensitivity , CAG repeat , androgenetic alopecia</keyword>
	<keyword>Pharmacogenomics treatment androgenetic alopecia woman</keyword>
</DOC>